Global Coalition on Aging Finds Chronic Kidney Disease A Troubling Blind Spot Among Chronic Diseases in the US

As societies get older, chronic kidney disease is growing as a leading cause of death.

Yet, there is a disturbing lack of attention or understanding, even among those at higher risk

New York, New York – September 6, 2023 – The Global Coalition on Aging (GCOA) – The World’s Leading Business Voice on Aging today announced the release of its survey on chronic kidney disease, “The Chronic Imperative Study.” The survey found that chronic kidney disease is a major blind spot for most Americans despite the disease impacting 250,000 lives a year and growing due to its alignment with the growing older adult population.

“Chronic kidney disease is a serious challenge to healthy aging,” said Michael Hodin, CEO of the Global Coalition on Aging. “The medical community and policy makers must come together to increase testing capabilities and drive awareness of this preventable and fast-growing disease.”

As part of the UN/WHO Decade of Healthy Ageing, the Global Coalition on Aging surveyed 1,000 Americans over the age of 18 on their understanding of and perceptions towards chronic kidney disease. Most notably, the survey found:

  1. Only 9% of people have explored chronic kidney disease and 58% were not familiar with the disease at all, despite the general high usage of the internet for medical information and high levels of regular doctor visits.
  2. Never-the-less, more than half (56%) were concerned with managing chronic kidney disease if diagnosed with it.
  3. Respondents over 60, where there is the greatest impact of the disease, were less familiar with chronic kidney disease than younger respondents, even though they’re more likely to see a doctor twice a year.

“As a member of the Global Coalition on Aging and in our capacity as life science company motivated to develop solutions that help, treat or potentially even cure diseases, we look forward to taking these important insights and using them with GCOA to help better inform patients, caregivers, and the healthcare community as well as society at large” said Dr. Michael Devoy, Chief Medical Officer, Bayer Pharmaceuticals. “Chronic kidney disease is growing in prevalence across aging societies in the U.S. and elsewhere. Much more can be done to raise awareness that will lead to addressing the disease before it is too late while saving lives, improving patient care quality, enabling healthier aging, and better managing health systems costs.”

The Global Coalition on Aging detailed several steps that should be taken to build awareness and increase prevention:

  • Create roundtable discussions of relevant stakeholders, including patients, caregivers and
  • Include chronic kidney disease in blood screenings and other prevention actions
  • Utilize social media and personal networks to spread awareness.
  • Build Chronic Kidney Disease information and risk attention to health programs of age-friendly cities, integrated care approaches and long-term care settings.
  • Work with employers to develop communication awareness for employees and their families.


About the Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path for fiscally sustainable economic growth, social value creation and wealth enhancement.

For more information, visit:


Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.